RESEARCH surgery, using the HbA1c level; and (ii) compliance with treatment, with the Morisky Medication Adherence Scale (MMAS-4). [11] Methods Study approval was obtained from the University of Cape Town Faculty of Health Sciences Human Research Ethics Committee (ref. no. UCT HREC: 386/2017) and the Western Cape Department of Health, and institutional approval was provided by all participating centres (ref. no. NHRD:WC_201709_018). The study was registered on Clinicaltrials.gov (ref. no. NCT03318055). Written informed consent was provided by all participants prior to enrolment. The study is presented according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. [12] This was a multicentre, prospective observational study performed at six government-funded hospitals in the Western Cape: Groote Schuur, New Somerset, Paarl, Victoria, Mitchell's Plain and George hospitals. A prestudy power calculation based on an expected prevalence of DM of 10% [10] and an estimated sample size of 500 (expected number of elective surgical procedures in the participating hospitals) allowed for an estimate of the prevalence with a 95% confidence interval (CI) of ±2.65%, i.e. 7.35 -12.65%. Convenience sampling was done during the daytime hours (07h00 -19h00) of a calendar week (Monday 16 October -Friday 20 October 2017).
Exclusion criteria were patient refusal or inability to consent, emergency and cardiac surgery, and pregnant and paediatric (<18 years of age) patients. All participants were seen preoperatively by the anaesthesia medical staff, and after written consent had been obtained, demographic and baseline data were collected and recorded on the case report form (CRF) (available as a supplementary file at http://www.samj.org.za/public/sup/simons_13898.pdf).
The diagnosis of DM in our study was based on recommendations of the Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA), [13] which state that the diagnosis can be made as follows: in an asymptomatic patient when any one of the following tests, repeated on separate days within a 2-week period, is confirmed: (i) fasting plasma glucose ≥7.0 mmol/L; (ii) 2 hours post glucose load ≥11.1 mmol/L; or (iii) HbA1c ≥6.5%. In the event that both a glucosebased test and the HbA1c test are done, if both are 'diagnostic' for diabetes, the diagnosis is confirmed.
HbA1c was measured in known diabetics who had not had a test result within the preceding 90 days. Screening for DM was done using finger-prick CBG testing in all consenting participants undergoing elective surgery. The mandatory starvation period of at least 6 hours for elective surgical patients was used as the fasting period for the fasting glucose measurement. Based on the recommended correction of CBG to reflect true plasma glucose (plasma glucose (mmol/L) = 0.102 + 1.066 × CBG), [13] a capillary glucose level of ≥6.5 mmol/L was taken as a cut-off to reflect a plasma level ≥7.0 mmol/L. Patients found to have a CBG of ≥6.5 mmol/L had an HbA1c test to confirm the diagnosis of diabetes.
HbA1c results were linked via a unique CRF-generated laboratory number. Data were recorded on paper CRFs, and captured electronically onto the Research Electronic Data Capture (REDCap) application. Access to REDCap was protected by username and password. Patient confidentiality and anonymity were protected through unique numerical code generation during electronic data capturing. Patients identified as having raised fasting CBG were given referral letters to their primary healthcare facilities for further investigations and management.
SEMDSA advocates aiming for an HbA1c level of ≤7% in most patients (well-controlled DM). An HbA1c level of 7.1 -8.5% is considered to indicate moderate control and may be acceptable in the following patient categories: elderly, frail, limited life expectancy, multiple comorbidities, severe vascular disease, advanced chronic kidney disease, recurrent severe hypoglycaemia, or unawareness of hypoglycaemia. [13] An HbA1c level of ≥8.5% is considered to indicate poor control. Compliance with treatment was assessed using the MMAS-4 score. [11] Non-compliance was taken as a positive response to two or more of the four questions in the MMAS-4.
Statistical analysis
Continuous variables with normal distribution were described as means and standard deviations (SDs). Between-group comparisons were performed using Fisher's exact test, except for age (t-test) and in contingency tables that were more than 2 × 2 comparisons (American Society of Anesthesiologists (ASA) classification and functional status), where Pearson's χ 2 test was used. The Statistical Package for the Social Sciences (SPSS) version 24 (SPSS Inc., USA) was used for data analysis.
Results
The study flow diagram is shown in Fig. 1 , and the breakdown of the contribution to final participant numbers from each hospital in Table 1 . Participants known to have DM comprised 16.1% (61/379; 95% CI 12.4 -19.8) of the study population. Of the 318 participants who had not previously been diagnosed with DM, 310 (97.5%) had CBG and, where appropriate, HbA1c results available. A new diagnosis of DM was made in an additional 1.6% (5/310; 95% CI 0.2 -3.0) of participants not previously known to have DM. The overall prevalence of DM was therefore 17.8% (66/371; 95% CI 13.9 -21.7). Of the 66 diabetic patients, 7.5% (5/66; 95% CI 1.2 -13.9) were diagnosed during the study.
The demographic details of the study population are shown in Table 2 . Univariate analysis showed an association between DM and increasing age, increasing ASA physical status classification, decreasing functional status and comorbidities. Based on positive responses to two or more questions on the MMAS-4 questionnaire, 12/60 participants (20.0%) were non-compliant with therapy for DM.
Discussion

Principal findings
In our study population, one in six participants presenting for surgery was diabetic. Of the participants with DM, 92.5% were known diabetics prior to surgery, but almost half had poor glycaemic control as reflected by an HbA1c level ≥8.5% ( Table 3 ).
The strength of this investigation was that it was a multicentre, prospective study that involved several regions in the Western Cape, SA. The research provided the most comprehensive data to date of the prevalence of diabetes in this elective adult surgical patient population, and therefore has implications for determining appropriate management plans for this population. In comparison with some previous prevalence studies, the study did not rely solely on self-reporting of DM or single CBG results, and we therefore believe that it is a more accurate representation of the true prevalence of diabetes and the degree of glycaemic control in these elective surgical patients.
Relation to other studies
The prevalence of DM in our study was higher than reported in non-surgical SA population studies. The International Diabetes Federation country-level DM estimates (5.4% for SA) were based on the weighted average of the scores of all data sources in the adult population. [1] The South African National Health and Nutrition RESEARCH Examination Survey (SANHANES) utilised a multistage disproportionate, stratified cluster sampling approach to the general population based on census data, and demonstrated a 9.2% prevalence of DM (self-reported, and HbA1c ≥6.5%) in the adult population. [3] The prevalence of DM increases with age, and the higher mean age of our study population than that of the general SA population probably contributes to the higher prevalence of DM reported. [14] Studies of surgical patients report a higher prevalence of DM than in the population overall. The South African Surgical Outcomes Study reported an SA national prevalence of self-reported DM of 10.1%. [10] This figure is considerably lower than ours. When investigating elective surgical patients in the Western Cape, Van der Spuy et al. [15] showed a prevalence of self-reported DM of 16%, which is in keeping with our findings. However, neither of these studies evaluated the prevalence of undiagnosed DM at the time of surgery, or the degree of glycaemic control.
Using CBG and HbA1c levels as screening and diagnostic tools, our study identified a low prevalence of undiagnosed DM of 1.6% (5/310) in this surgical population. This is a considerably lower figure than that reported in a general population study by Bailey et al., [16] which estimated a prevalence of undiagnosed DM (based on random CBG measurement) in the Western Cape of 12.7%. In 2012, Erasmus et al. [17] found a prevalence of undiagnosed DM (based on oral glucose tolerance tests and HbA1c) of 18.2% in adults in a community in Bellville, Western Cape. The reasons for the lower prevalence in our study probably include: (i) the stringent diagnostic criteria we applied; and (ii) the fact that all participants in our study had been assessed preoperatively by a number of healthcare practitioners.
Clinical implications
Our data suggest that DM screening for patients accessing elective surgery (often via primary healthcare) is well established in the studied healthcare services. Based on our findings, we suggest that screening for DM is not a priority in the preoperative period. This proposal is in keeping with conclusions from a systematic review that routine blood glucose or HbA1c levels are not needed in otherwise well non-diabetic patients presenting for general (non-orthopaedic or non-vascular) surgery. [18] However, cognisance must be taken of the fact that a small number of patients do present with undiagnosed DM. The prevalence of DM and access to primary healthcare and hospitals are extremely variable in SA, and care must be taken in generalising our findings over too broad a population base.
Numerous studies have shown that poor preoperative glycaemic control is associated with increased complication rates in the perioperative period. These include increased length of stay, [4] an increased risk of failure of total ankle replacements, [5] increased infection rates in hip and knee arthroplasty, [6] and an increased risk of poor postoperative glycaemic control and postoperative complications. [7] In 2015, Kallio et al. [19] demonstrated that referral of poorly controlled diabetic patients (HbA1c >10%) to primary healthcare services for optimisation of glycaemic control before proceeding with total joint arthroplasty resulted in lower complication rates and shorter hospital stays.
The UK National Health Service Consensus Guidelines of 2011, [20] endorsed by the Association of Anaesthetists of Great Britain and Ireland Working Party, [21] recommend postponing elective surgery in patients with an HbA1c level ≥8.5%, to allow for improved glycaemic control. In our study, 47% of diabetic participants had an HbA1c exceeding this level. If these guidelines were to be adopted in the Western Cape, it is likely that a significant proportion of diabetic patients would have their surgery postponed. 
RESEARCH
In our resource-limited environment, patients may experience long delays in accessing elective surgery. Last-minute postponement of surgery to allow for improved glycaemic control may not be practical. If poor control is identified timeously, the long waiting period presents an opportunity for optimisation of treatment without increasing the delay before surgery. Limited access to good-quality diabetes care is a major concern: an analysis of data from the SANHANES study estimated that only 19.4% of patients with DM in SA are both identified and well controlled, [22] which is in keeping with our findings, where only 24.6% of patients known to have DM had good control (HbA1c ≤7%). As a secondary outcome, compliance was assessed using the MMAS-4. Only one of every five participants was noted to be noncompliant, which is similar to the prevalence of self-reported noncompliance with DM medication of 30% in Limpopo Province. [23] In our study, no conclusions could be drawn with regard to the correlation between compliance and glycaemic control. Verbal questionnaires to establish compliance have limited reliability. We used the MMAS-4 because this tool has been described as nearest to the gold standard. [24] Despite the reported compliance rate of 80% in our study population, 47.4% of the diabetic participants were found to be poorly controlled, with an HbA1c level of ≥8.5%. Interpreting the reasons for the disparity between reported medication compliance and glycaemic control is complex. Factors contributing to glycaemic control may include the prescribing and availability of correct medication, as well as lifestyle factors such as exercise and diet.
Study limitations
This study has some limitations. A smaller number of patients was recruited than we expected (379 v. 500) owing to the withdrawal of one of the hospitals initially planned to be an active site. This minimally increased the 95% CI associated with estimation of the prevalence of diabetes in this population from 5.3 to 8.
Nil per os guidelines followed in the participating hospitals were a minimum of 6 hours for solid food and 2 hours for clear fluids. In practice, most patients had longer nil per os times than this minimum requirement. The SEMDSA guidelines state that 'fasting is defined as no caloric intake for at least eight hours' . [13] It is possible that participants may have had oral or intravenous glucose containing fluids within 8 hours preoperatively, which may have affected the CBG result. Fasting status would not affect HbA1c results. Since HbA1c was used as a defining result for DM, we are confident that we did not overestimate the prevalence of DM in our study population.
The SEMDSA guidelines advise that bedside tests (glucose and HbA1c) should not be used to diagnose DM unless laboratory-based tests are unavailable. [13] For reasons of clinical convenience, and to make our study practicable, we used finger-prick CBG levels. We conducted laboratory HbA1c testing as a defining result to diagnose DM. The SEMDSA guidelines also state that 'if only one of these tests is abnormal, a second abnormal result of the same testing method is required to confirm the diagnosis of diabetes on a different day, preferably within two weeks' . [13] Fourteen of our participants had a raised CBG level, with an HbA1c level <6.5%, and were not followed 
Suggested further research
This study provides an objective assessment of the prevalence and glycaemic control of DM in the perioperative patient population in the Western Cape, SA. The poor control of DM in the perioperative period suggests that further research is needed to evaluate perioperative complication rates in these patients. Interventions to improve longterm glycaemic control should be identified in elective surgical patients, and the effects of their introduction should be studied.
Conclusions
DM is a common disease that is associated with increased perioperative complications. It was well diagnosed but poorly managed in our study population. We recommend that early identification of poorly managed DM (by HbA1c measurement) should be prioritised in elective surgical patients. Doing this could result in timeous referral to the appropriate services for improvement of glycaemic control before surgery, and in turn allow time for improvement of preoperative management of DM, without causing a significant increase in surgical waiting times. Overall, the goal would be lower perioperative complication rates.
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